Moleculin Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Moleculin Biotech using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-13 | $-17.00 | $-5.50 | -209.1 % |
| Q2 | 2025-08-12 | $-12.25 | $-4.00 | -206.3 % |
| Q1 | 2025-05-13 | $-17.25 | $-17.75 | 2.82 % |
| Q4 | 2025-03-21 | $-9.25 | $-33.25 | 72.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
Moleculin Biotech (MBRX) is scheduled to report earnings on March 20, 2026. The last reported earnings were for reported on November 13, 2025 for Q3.
The Actual EPS was $-17.00, which missed the estimate of $-5.50.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
Browse earnings estimates, EPS, and revenue on all stocks.